Osaka Prefecture and Osaka City Open Doors to International Investors – Free Online Participation Available

Osaka Prefecture and Osaka City announce the Osaka Finance Forum, featuring Life Science and Healthcare startups pitch, to be held at Nakanoshima Qross, the newly opened international hub for future medicine commercialization that unites medical institutions, startups, and industry partners under one roof. This hybrid event, set in Osaka's thriving life sciences ecosystem, offers both in-person and online participation.

Known as 'a town of pharmaceuticals' for 400 years, Osaka hosts numerous pharmaceutical companies, world-leading universities, and research facilities, primarily in Northern Osaka. This rich ecosystem, supported by industry-academia-government collaboration, makes Osaka an ideal hub for life sciences innovation.

Event Details

  • Venue: Nakanoshima Qross 2F “Qrossover Lounge Yume” and Online
  • Format: Hybrid (In-person and online)
  • Focus: Life Science and Healthcare
  • Registration: https://osakafinanceforum1125.peatix.com
    (Deadline: November 22, 2024)
  • Language: English (Simultaneous interpretation available)

Program (All times in JST)

  • 16:30 Greetings from the organizer
  • 16:40 Keynote speech
  • 16:50 Pitches by start-ups in Osaka/Kansai
  • 17:50 Break
  • 18:00 Pitches by start-ups in Osaka/Kansai
  • 19:00 Networking (conducted on-site only)
  • 20:00 Closing


Highlights

  • Pitches from approximately 10 selected Kansai startups in Life Science and Healthcare
  • One-on-one business meetings available at booths throughout the event
  • Networking opportunities (on-site only)

Participation

This event is free of charge for all attendees, both in-person and online.

Registration deadline: Friday, November 22, 2024

How to register:

Please register using the registration form at https://osakafinanceforum1125.peatix.com

Osaka: A Hub for Life Sciences

With a 400-year history as “a town of pharmaceuticals,” Osaka boasts a rich ecosystem of pharmaceutical companies, world-leading universities, and research facilities. The city's collaborative environment between industry, academia, and government creates an ideal setting for life sciences innovation.

For Global Investors

The Osaka Finance Forum offers a valuable and unique opportunity to engage with Japan's most promising Life Science and Healthcare startups from anywhere in the world. This event provides unparalleled access to cutting-edge innovations emerging from the Kansai region, allowing investors to be at the forefront of technological advancements in fields such as biotechnology, medical devices, and digital health.

Participating Startups

A total of about 10 companies are scheduled to pitch. Information about the participating startups will be updated on the event website as it becomes available. Here are some of the confirmed participants:

Company name Company overview
At Co., Ltd. Our mission is looking after the health of people all over the world! Visualize and quantify subcutaneous fingertip capillaries non-invasively!
SleepWell Inc. Revolutionizing depression diagnosis with sleep EEG SaMD. Establishing the new gold-standard biomarker for mental health!
PaMeLa Inc. A startup from Osaka University developing an AI that quantifies pain, with the aim of reducing the average level of pain in the world.
COGNANO, Inc. COGNANO leverages reverse-data science to discover novel targets, comprehensively solving unmet medical needs.
C4U CORPORATION C4U is a biotech start-up company which was born from Osaka University and is pursuing an implementation of a novel gene editing platform, CRISPR-Cas3.
Immunosens Co., Ltd. A startup from Osaka University, focused on developing a small, highly sensitive rapid POCT device utilizing electrochemical immunoassay method known as GLEIA.
Revascular Bio Co., Ltd. Providing a novel solution for vascular diseases with the world’s first patented technology of ‘stem cells that create blood vessels.
Vision Care Inc. Research and development of regenerative medicine and gene therapy for diseases of the outer retina, as well as low vision care and other support for the visually impaired.
JiMED, Inc. Development of a wireless implantable brain-computer interface that enables the control of external devices using brain waves.